The Telegraaf found ten TikTok sellers, and one told the paper his sales jumped from a few jars a day to over 100. The Dutch health inspectorate warns of hospital stays and deaths.
Recap by typeshit. Full story at NL Times.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Gannan Medical University researchers screened 6,000 candidates from Hypsizygus marmoreus and found peptides that may help cut sodium without losing flavor.
8:28
A weight loss doctor walks through retatrutide, which she calls the most anticipated obesity drug currently in clinical trials.
Loading…